Clinical trial registry record

Imaging of the Angiofibrotic Switch in Neovascular AMD

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 20, 2020.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03838679
Last registry update
February 20, 2020
Status
Unknown
Phase
Phase not reported
Sponsor
Medical University of Vienna
Enrollment
120
Countries
Austria
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
120
Population
ALL · 50 Years
Duration
2019-05-01 to 2022-04-28
Intervention
Best-corrected Visual acuity testing (BCVA); Optical coherence tomography (OCT); Color fundus photography (CFP); Optical coherence tomography angiography (OCTA); Polarization-sensitive optical coherence tomography (PS-OCT); Microperimetry (MP); Adaptive-optics optical coherence tomography (AO-OCT); Fluorescein angiography (FA)
Comparator
Not reported
Outcomes measured
Detection of subretinal fibrosis by PS-OCT — 15 months; Extension of fibrosis area quantified on PS-OCT and correlated to standard imaging modalities — 33 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 100%Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

vision aging
Read the original source →Export JSON